Assessment of diagnostic accuracy of perfusion MR imaging in primary and metastatic solitary malignant brain tumors

American Journal of Neuroradiology

Volumn 26, Issue 9, 2005, Pages 2187-2189

  Bulakbasi, Nail ^a   Kocaoglu, Murat ^a   Farzaliyev, Anar ^a   Tayfun, Cem ^a   Ucoz, Taner ^a   Somuncu, Ibrahim ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; ASTROCYTOMA; BRAIN BLOOD VOLUME; BRAIN TUMOR; CANCER GRADING; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; ECHO PLANAR IMAGING; FEMALE; GLIOMA; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; METASTASIS; PERFUSION WEIGHTED IMAGING; SCHOOL CHILD; TUMOR DIFFERENTIATION; BLOOD VOLUME; BRAIN CIRCULATION; CHILD; MAGNETIC RESONANCE ANGIOGRAPHY; MIDDLE AGED; PATHOLOGY; VASCULARIZATION;

CONTRAST MEDIUM;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BLOOD VOLUME; BRAIN NEOPLASMS; CEREBROVASCULAR CIRCULATION; CHILD; CONTRAST MEDIA; ECHO-PLANAR IMAGING; GLIOMA; HUMANS; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MIDDLE AGED;

EID: 32944455004     PISSN: 01956108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Lev MH, Ozsunar Y, Henson JW, et al. Glial tumor grading and outcome prediction using dynamic spin-echo MK susceptibility mapping compared with conventional contrast-enhanced MB: confounding effect of elevated rCBV of oligodendrogliomas [corrected]. AJNR Am J Neuroradiol 2004;25:214-221
2. Knopp EA, Cha S, Johnson G, et al. Glial neoplasms: dynamic contrast-enhanced T2*-weighted MR imaging. Radiology 1999;211:791-798
3. Cha S, Knopp EA, Johnson G, et al. Intracranial mass lesions: dynamic contrast-enhanced susceptibility-weighted echo-planar perfusion MR imaging. Radiology 2002;223:11-29
4. Wetzel SG, Cha S, Johnson G, et al. Relative cerebral blood volume measurements in intracranial mass lesions: interobserver and intraobserver reproducibility study. Radiology 2002;224:797-803
5. Wong JC, Provenzale JM, Petrella JR. Perfusion MR imaging of brain neoplasms. AJR Am J Roentgenol 2000;14:1147-1157
6. Su M-Y, Muller A, Lao X, Nalcioglu O. Tumor characterization with dynamic contrast enhanced MRI using MR contrast agents of various molecular weights. Magn Reson Med 1998;39:259-269
7. Aronen HJ, Gazit IE, Louis DN, et al. Cerebral blood volume maps of gliomas: comparison with tumor grade and histologic findings. Radiology 1994;191:41-51
8. Brem S, Cotran R, Folkman. J. Tumor angiogenesis: a quantitative method for histological grading. J Natl Cancer Inst 1972;48:347-356
9. Rampling R, James A. Papanastassiou V. The present and future management of malignant brain tumours: surgery, radiotherapy, cnemotherapy. J Neurol Neurosurg Psychiatry 2004;75(suppl 2):ii24-ii30
10. Leach MO, Brindle KM. Evelhoch JL, et al. Assessment of antiangiogenic and antivascular therapeutics using MRI: recommendations for appropriate methodology for clinical trials. Br J Radiol 2003;76 (suppl 1):S87-S91
11. Akella NS, Twieg DB, Mikkelsen T, et al. Assessment of brain tumor angiogenesis inhibitors using perfusion magnetic resonance imaging: quality and analysis results of a phase I trial. J Magn Reson Imaging 2004;20:913-922
12. McKnight TR, von dem Bussche MH, Vigneron DB. Histopathological validation of a three-dimensional magnetic resonance spectroscopy index as a predictor of tumor presence. J Neurosurg 2002;97:794-802
13. Schwartz RB. Neuroradiology of brain tumors. Neurol Clin 1995;13:723-756
14. Bitzer M, Klose U, Nägel T, et al. Echo planar perfusion imaging with high spatial and temporal resolution: methodology and clinical aspects. Eur Radiol 1999;9:221-229
15. Uematsu H, Maeda M, Sadato N, et al. Vascular permeability: quantitative measurement with doable echo dynamic MR imaging: theory and clinical application. Radiology 2000;214:912-917
16. Jackson A, Kassner A, Zhu XP, Li KL. Reproducibility of T2* blood volume and vascular tortuosity maps in cerebral gliomas. J Magn Reson Imaging 2001;14:510-516
17. Barbier EL, Lamalle L, Décorps M. Methodology of brain perfusion imaging. J Magn Reson Imaging 2001;13:496-520
18. Weisskoff RM, Rosen BR. Noninvasive determination of regional cerebral blood flow in rats using dynamic imaging with Gd (DTPA). Magn Reson Med 1992;25:211-212
19. Intern application guide. Release 9. Vol 2: Scan methods. Best, the Netherlands: Philips Medical Systems;2002:211-217
20. Rosen BR, Belliveau JW, Vevea JM, Brady TJ. Perfusion imaging with NMR contrast agents. Magn Reson Med 1990;14:249-265
21. Sugahara T, Korogi Y, Kochi M, et al. Perfusion-sensitive MR imaging of gliomas: comparison between gradient-echo and spinecho echo-planar imaging techniques. AJNR Am J Neuroradiol 2001;22:1306-1315
22. Kleihues P, Cavenee WK. WHO Classification of tumours: pathology and genetics of tumours of the nervous system. IARC, Lyon France, 2000:9-70
23. Law M, Yang S, Wang H, et al. Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging AJNR Am J Neuroradiol 2003;24:1989-1998
24. Shin JH, Lee HK, Kwun BD, et al. Using relative cerebral blood flow and volume to evaluate the histopathologic grade of cerebral gliomas: preliminary results. AJR Am J Roentgenol 2002;179:783-789
25. Folkman J. Role of angiogenesis in tumor growth and metastasis Semin Oncol 2002;29(suppl 16):15-18
26. Cha S, Johnson G, Wadghiri YZ, et al. Dynamic, contrast-enhanced perfusion MRI in mouse gliomas: correlation with histopathology. Magn Reson Med 2003;49:848-855
27. Pathak AP, Schmainda KM, Ward BD, et al. MR-derived cerebral blood volume maps: issues regarding histological validation and assessment of tumor angiogenesis. Magn Reson Med 2001;46:735-747
28. Law M, Yang S, Babb JS, et al. Comparison of cerebral blood volume and vascular permeability from dynamic susceptibility contrast-enhanced perfusion MR imaging with glioma grade. AJNR Am J Neuroradiol 2004;25:746-755
29. Sugahara T, Korogi Y, Kochi M, et al. Correlation of MR imaging-determined cerebral blood volume maps with histologic and angiographic determination of vascularity of gliomas. AJR Am J Roentgenol 1998;171:1479-1486
30. Daldrup H, Shames DM, Wendland M, et al. Correlation of dynamic contrast-enhanced magnetic resonance imaging with histologic tumor grade: comparison of macromolecular and small-molecular contrast media. Pediatr Radiol 1998;28:67-78
31. Roberts HC, Roberts TP, Brasch RC, Dillon WP. Quantitative measurement of microvascular permeability in human brain tumors achieved using dynamic contrast-enhanced MR imaging: correlation with histologic grade. AJNR Am J Neuroradiol 2000;2 891-899
32. Ludemann L, Grieger W, Wurm R, et al. Comparison of dynamic contrast-enhanced MRI with WHO tumor grading for gliomas. Eur Radiol 2001;11:1231-1241
33. Oh J, Henry RG, Pirzkall A, et al. Survival analysis in patients with glioblastoma multiforme: predictive value of choline-to-N-acetylaspartate index, apparent diffusion coefficient, and relative cerebral blood volume. J Magn Reson Imaging 2004;19:546-554
34. Lee SJ, Kim JH, Kim YM, et al. Perfusion MR imaging in glioma comparison with histologic tumor grade. Korean J Radiol 2001; 1-7
35. Aronen HJ, Pardo FS, Kennedy DN, et al. High microvascular blood volume is associated with high glucose uptake and tumor angiogenesis in human gliomas. Clin Cancer Res 2000;6:2189-2200
36. Roberts HC, Roberts TP, Bollen AW, et al. Correlation of microvascular permeability derived from dynamic contrast-enhanced MR imaging with histologic grade and tumor labeling index: a study in human brain tumors. Acad Radiol 2001;8:384-391
37. Provenzale JM, Wang GR, Brenner T, et al. Comparison of permeability in high-grade and low-grade brain tumors using dynamic susceptibility contrast MR imaging. AJR Am J Roentgenol 2002;178:711-716
38. Roberts HC, Roberts TP, Ley S, et al. Quantitative estimation of microvascular permeability in human brain tumors: correlation of dynamic Gd-PTPA-enhanced MR imaging with histopathologic grading. Acad Radiol 2002;(suppl 1):S151-S155
39. Schmainda KM, Rand SD, Joseph AM, et al. Characterization of a first-pass gradient-echo spin-echo method to predict brain tumor grade and angiogenesis. AJNR Am J Neuroradiol 2004;25:1524-1532
40. Tropres I, Lamalle L, Peoc'h M, et al. In vivo assessment of tumoral angiogenesis. Magn Reson Med 2004;51:533-541
41. Cha S, Tihan T, Crawford F, et al. Differentiation of low-grade oligodendrogliomus from low-grade astrocytomas by using quantitative blood-volume measurements derived from dynamic susceptibility contrast-enhanced MR imaging. AJNR Am J Neuroradiol 2005;26:266-273
42. Law M, Cha S, Knopp EA, et al. High-grade gliomas and solitary metastases: differentiation by using perfusion and proton spectroscopic MR imaging. Radiology 2002;222:715-721
43. Chiang IC, Kuo YT, Lu CY, et al. Distinction between high-grade gliomas and solitary metastases using peritumoral 3-T magnetic resonance spectroscopy, diffusion, and perfusion imagings. Neuroradiology 2004;46:619-627
44. Kremer S, Grand S, Berger F, et al. Dynamic contrast-enhanced MRI: differentiating melanoma and renal carcinoma metastases from high-grade astrocytomas and other metastases. Neuroradiology 2003;45:44-49